Switzerland · Hospital & Health Care startup
Switzerland · GlycoVaxyn
GlycoVaxyn develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology.
Funding reportedLast round: Grant
What company datasets say GlycoVaxyn raised
Funding, as reported
Reported in all34.3Min the source's currency
Rounds4
Last roundGrant
Last round dateMay 2010
Investors listed3
How it ended, so far
Exit
ExitBuyerPriceWhen
Hospital & Health Care in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put GlycoVaxyn in front of investors. Or tell us what we have wrong.